Home » Chinese Trial Misconduct Delayed Bristol-Myers Medicine
Chinese Trial Misconduct Delayed Bristol-Myers Medicine
U.S. drug regulators are intervening in the recent trend of shipping clinical trials off to China after a series of errors, claiming that trial data is sloppy.
Bloomberg
Bloomberg
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May